Page last updated: 2024-08-21

thiazolidines and Leukemia, Lymphocytic, T Cell

thiazolidines has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ball, LE; DeAngelo, DJ; Hardiman, G; Kraft, AS; Luevano, LA; Minden, MD; Padi, SK; Song, JH; Warfel, NA1

Other Studies

1 other study(ies) available for thiazolidines and Leukemia, Lymphocytic, T Cell

ArticleYear
Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
    Oncotarget, 2016, Apr-12, Volume: 7, Issue:15

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Biphenyl Compounds; Cell Proliferation; Clinical Trials, Phase I as Topic; Humans; Insulin Receptor Substrate Proteins; Leukemia, Experimental; Leukemia, T-Cell; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Staging; Neoplasms; Phosphorylation; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Signal Transduction; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016